Artificial Heart-Lung Machine Market Research Report, Growth Factors, Industry Insight and Forecast 2022-2027

IMARC Group's latest report, titled "Artificial Heart-Lung Machine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", offers a comprehensive analysis of the industry, which comprises insights on artificial heart-lung machine market. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global artificial heart-lung machine market size reached US$ 270.6 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 339.5 Million by 2027, exhibiting a growth rate (CAGR) of 3.77% during 2022-2027.

An artificial heart-lung machine also referred to as an oxygenator pump or cardiopulmonary bypass (CPB), is used during heart and lung transplants, coronary artery bypass, and other cardiac surgeries. It temporarily performs functions to enable the surgeon to operate in motion and bloodless surgical field. Artificial heart-lung machines consist of a chamber that receives blood, which is then circulated and oxygenated to all body parts. These pumps have assisted in making significant advances in managing severe respiratory failure and in the field of cardiac surgeries. As a result, artificial heart-lung machine finds widespread applications across hospitals, clinics, ambulatory surgical centers, etc.

Get a Free Sample Copy of this Report: https://www.imarcgroup.com/artificial-heart-lung-machine-market/requestsample

Market Trends:

The escalating prevalence of cardiovascular diseases and organ failures, owing to the various environmental and lifestyle changes, is primarily driving the artificial heart-lung machine market. Besides this, the launch of several policies by the government bodies to provide improved healthcare facilities to the patients is further augmenting the market growth. Moreover, the growing popularity of modular artificial heart-lung machines that are cost-effective, safe, and user-friendly is also catalyzing the global market. Apart from this, the rising research and development (R&D) activities to modernize the current models of oxygenator pumps are acting as significant growth-inducing factors. Furthermore, the elevating requirement for this device to offer flexibility to doctors as it is portable and can be operated on rechargeable batteries is expected to bolster the artificial heart-lung machine market in the coming years.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/artificial-heart-lung-machine-market

Competitive Landscape with Key players:

The report has also analysed the competitive landscape of the market with some of the key players being.

• Medtronic Inc
• Sorin Group
• MAQUET GmbH & Co. KG
• Terumo Corporation
• C.R. Bard Inc
• Tianjin Medical
• Edwards Lifesciences
• Jarvik Heart
• Braile Biomédica
• SynCardia

Artificial Heart-Lung Machine Market Segmentation:

Our report has categorized the market based on region, type, application and end use industry.

Breakup by Type:
• Single Roller Pump
• Double Roller Pump

Breakup by Application:
• Cardiac Surgeries
• Lung Surgeries
• Acute Respiratory Failure Treatment
• Others

Breakup by End User:
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others

Breakup by Region:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

We are updating our reports, If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.